Caterina Viscomi

Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro

Pierfrancesco Tassone, Pierosandro Tagliaferri, Caterina Viscomi et al. · British Journal of Cancer · 2003 · 155 citations · Full text

The farnesyl transferase inhibitor R115777 (Zarnestra®) synergistically enhances growth inhibition and apoptosis induced on epidermoid cancer cells by Zoledronic acid (Zometa®) and Pamidronate

Michele Caraglia, Anna Maria D’Alessandro, Monica Marra et al. · Oncogene · 2004 · 74 citations

Molecular Pharmacology, Medicinal Chemistry, Zoledronic Acid +12

<i>In vivo</i> anti‐myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor

Paola Neri, Pierosandro Tagliaferri, Maria Teresa Di Martino et al. · British Journal of Haematology · 2008 · 63 citations · Full text

Chemoprevention Strategy, Histone Deacetylase Inhibitor, Immunology +20

C-Raf antagonizes apoptosis induced by IFN-α in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A

Annalisa Lamberti, Olimpia Longo, Monica Marra et al. · Cell Death and Differentiation · 2007 · 58 citations · Full text

Cancer Research, C-raf Antagonizes Apoptosis, Lung Inflammation +12

The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro‐apoptotic activity of interferon‐α through the inhibition of multiple survival pathways

Michele Caraglia, Monica Marra, Caterina Viscomi et al. · International Journal of Cancer · 2007 · 20 citations